Novozymes, Chr. Hansen gain EU merger approval following lactase concessions
MLex Summary: Danish bioscience companies Novozymes and Christian Hansen have won EU approval to merge. Regulators approved by the deal on condition Chr. Hansen divest its project to manufacture lactase, along...To view the full article, register now.
Already a subscriber? Click here to view full article